Support for health professionals to complement the Antidepressant Deprescribing Plan. Includes information on tapering options and distinguishing withdrawal symptoms from relapse.
To help us understand the impact of our resources, please let us know if you are downloading to use with a patient or for general educational purposes.
The Maudsley Deprescribing Guidelines: Antidepressants, Benzodiazepines, Gabapentinoids and Z-drugs https://www.wiley.com/en-us/The+Maudsley+Deprescribing+Guidelines%3A+Antidepressants%2C+Benzodiazepines%2C+Gabapentinoids+and+Z-drugs-p-9781119823025
Royal Australian and New Zealand College of Psychiatrists. Mood disorders: clinical practice guidelines. 2020 https://www.ranzcp.org
Therapeutic Guidelines https://tgldcdp.tg.org.au/viewTopic?etgAccess=true&guidelinePage=Psychotropic&topicfile=major-depression
Royal College of Psychiatrists (UK). Stopping antidepressants, 2021 https://www.rcpsych.ac.uk/mental-health/treatments-and-wellbeing/stopping-antidepressants
AMH Aged Care Companion, 2024 https://agedcare.amh.net.au/chapters/neurological-mental-health/depression
Van Leeuwen E. Cochrane Database Syst Rev. 2021; 2021(4): CD013495.